A series of L-cysteine (L-Cys), glutathione (GSH), and Nacetyl-L-cysteine (NAC) conjugates of phenethyl (PEITC), benzyl (BITC), and 6-phenylhexyl isothiocyanate (PHITC) were studied for their inhibitory activity toward metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung microsomes. Selected compounds, PEITC, PEITCϪGSH, PEITCϪNAC and PHITCϪNAC, were also assayed for the potential chemopreventive activity toward NNK-induced lung tumorigenesis in A/J mice. Results showed that PEITC and its conjugates inhibited NNK metabolism with decreasing potency: PEITC < PEITCϪGSH > PEITCϪCys > PEITCϪNAC. PHITC and its GSH and NAC conjugates exhibited nearly 10 times higher inhibitory activity toward NNK metabolism than the PEITC counterparts. In the tumor bioassay, as expected, the conjugates exhibited inhibitory activity against lung tumorigenesis induced by NNK. PEITCϪGSH was not inhibitory at 4 µmol/mouse, but it inhibited~32% of lung tumor multiplicity at 8 µmol/mouse. PEITCϪNAC at 5 and 20 µmol/mouse both inhibited~30% tumor multiplicity. Among all the conjugates examined, PHITCϪNAC was the most potent. At a 5-µmol dose, it completely inhibited tumor multiplicity and incidence to the background level observed in the control group. These results revealed that the structureϪactivity relationships of the conjugates are similar to those found with their parent isothiocyanates (ITCs), i.e., the potency increased with the increasing alkyl chain length from two to six carbons in arylalkyl ITCs, suggesting that a common active species is involved. The inhibitory activity of ITC conjugates and the expected low toxicity make thiol conjugates of ITC a promising new series of chemopreventive agents.
Introduction
Isothiocyanates (ITCs*), both naturally occurring and synthetic, have emerged as a class of promising chemopreventive agents (1) (2) (3) (4) (5) (6) . Accumulated experimental data have revealed that *Abbreviations: CYP, cytochrome P450; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; BITC, benzyl isothiocyanate; PEITC, phenethyl isothiocyanate; PHITC, 6-phenylhexyl isothiocyanate; Cys, L-cysteine; NAC, N-acetyl-L-cysteine; GSH, glutathione; GST, glutathione S-transferase; BITCϪGSH, conjugate of benzyl isothiocyanate and glutathione; DMSO, dimethylsulfoxide; ITCs, isothiocyanate; NMBA, N-nitrosomethylbenzylamine; MS, mass spectrometer; NMR, nuclear magnetic resonance.
organic ITCs play important roles in modulating the activation and detoxification of carcinogens (7) (8) (9) . Arylalkyl ITCs are potent inhibitors of mouse and rat cytochrome P-450 (CYP) enzymes responsible for metabolic activation of nitrosamines to alkylating species (7, 8) . Inhibition of metabolic activation of tobacco nitrosamines such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N-nitrosomethylbenzylamine (NMBA) reduces the levels of DNA methylation and, consequently, decreases the number of neoplasms in the lung and esophagus in A/J mice and F344 rats, respectively (10) (11) (12) (13) . ITCs, such as sulforaphane found in broccoli, are inducers of phase II enzymes, such as glutathione S-transferases (GST) and quinone reductases, which enhance the detoxification of carcinogens, a mechanism contributing to anticarcinogenic activity (9, 14) . Similar effects on phase I and II enzymes have also been observed in humans. Recent studies showed that the consumption of vegetables rich in glucosinolates, precursors of ITCs, led to elevated GST levels (15, 16) ; and ingestion of watercress, a good source of phenethyl isothiocyanate (PEITC), inhibited the metabolic activation of NNK in smokers (17, 18) . These findings are intriguing because they are consistent with data from epidemiologic studies that have linked the consumption of cruciferous vegetables with the reduced risk of certain human cancers (19) (20) (21) .
Conjugation with glutathione (GSH) is a major metabolic route of ITCs in rodents and humans (17, 22, 23) . More than half of the isothiocyanates administered to humans was excreted as the N-acetyl-L-cysteine (NAC) conjugates in urine within 12 h (17, 24, 25) . Both N-acetyl-L-cysteine (NAC) and L-cysteine (L-Cys) conjugates are degradation products of ITCϪGSH via the mercapturic acid pathway. We have recently examined the activity of these conjugates in the inhibition of hepatic microsomal cytochrome P450 (CYP) activities in vitro. These studies showed that the conjugates, e.g. PEITCϪGSH, PEITCϪCys and PEITCϪNAC, inhibit CYP2E1, 2B1 and 1A1 and 2 in rat or human liver microsomes (26, 27) . These findings are important because they not only suggest the involvement of ITC conjugates in the mechanism by which ITCs inhibit tumorigenesis, but they also raise the potential that these conjugates themselves are inhibitors of tumorigenesis. This prospect is supported by the observation that the conjugates can gradually release the active ITCs via a dissociation mechanism (26, (28) (29) (30) . Furthermore, the development of less toxic ITC-related compounds has recently become more imminent since several studies have shown adverse effects of chronic administration of ITCs (31, 32) . In this study, we examined the effects of ITC conjugates in the metabolism of NNK by mouse lung microsomes and in lung tumorigenesis of A/J mice treated with NNK. Ci/mmol; purity Ͼ95%) was purchased from Chemsyn Science Laboratories (Lenexa, KS) and was further purified by reverse-phase HPLC before use. Unlabeled NNK was synthesized as previously described (33) . All other chemicals from commercial sources were reagent grade. ITC conjugates were synthesized and characterized previously in this laboratory (26) . 6-Phenylhexylisothiocyanate (PHITC)ϪNAC was newly synthesized and characterized for the present study using the method previously described (26) 10 .00 (t, 1H). Animals Female A/J mice were obtained from the Jackson Laboratories (Bar Harbor, ME). Animals were used in bioassay at 7 weeks of age after 1 week of quarantine. Mice were fed AIN-76A semipurified diet with 5% corn oil (Dyets; Bethlehem, PA) and given tap water ad libitum. They were maintained under the following standard conditions: 20 Ϯ 2°C, 50 Ϯ 10% relative humidity, and a 12-h light, 12-h dark cycle. NNK metabolism in mouse lung microsomes Lung microsomes were prepared from mice at the age of 6-7 weeks as previously described and were stored at Ϫ80°C before use (11) . The protein concentration was determined using the Lowry method (34). The incubation mixture contained 100 mM sodium phosphate buffer, pH 7.4, an NADPHgenerating system (5 mM glucose-6-phosphate, 1 mM NADP ϩ and 1.5 units of glucose-6-phosphate dehydrogenase), 5 mM sodium bisulfite, 1 mM EDTA, 3 mM MgCl 2 , 10 µM NNK (containing 1 µCi of ]NNK), 0.1 mg lung microsomal protein, and 0-5 µM ITCs or the conjugates in a total volume of 0.4 ml. ITCs and conjugates were dissolved in methanol and the phosphate buffer respectively, and used at 1% of the total incubation volume. At this concentration, methanol did not affect NNK metabolism. The reaction mixture was incubated for 20 min at 37°C and terminated by adding 25% zinc sulfate and saturated barium hydroxide. The sample was centrifuged and filtered and a 0.2-ml aliquot was analyzed by co-injection with 5 µl of NNK metabolite standards using the HPLC conditions developed previously (35) . A reversephase HPLC system equipped with a Radiomatic Flo-One/Beta radioflow detector (Radiomatic Instruments and Chemical Company, Tampa, FL) was used for the analysis of NNK metabolites. All experiments were done in duplicate. The data were plotted as rate of formation of each metabolite versus the concentration of the inhibitor tested. The IC 50 s were obtained from the plot by graphic interpolation. Pulmonary adenoma bioassay in A/J mice NNK was dissolved in saline at a concentration of 100 mM. PEITC was dissolved in corn oil with 10% of dimethylsulfoxide (DMSO). In our previous studies, corn oil was the only vehicle for ITC administration. ITC conjugates, however, did not dissolve in either corn oil or water at the concentrations studied. A small amount of DMSO (10% of the total volume) was used to completely dissolve conjugates before adding corn oil or water to make a suspension. PEITCϪGSH was suspended in water with 10% DMSO at 4 and 8 µmol/0.1 ml. PEITCϪNAC and PHITCϪNAC were suspended in corn oil with 10% DMSO at the concentrations of 5 or 20 µmol/0.1 ml, and 1 or 5 µmol/0.1 ml, respectively. The single-dose protocol for NNK lung tumor induction in A/J mouse was used (36) . The bioassay for a single dose of testing compounds as inhibitors using this animal model has been described previously (37) . In brief, 30 mice were each given a single dose of 10 µmol NNK (in 0.1 ml saline) by i.p., serving as the NNK control group. Groups of 15 or 18 mice were treated with test agents by gavage in 0.1 ml vehicle as solution or suspension at doses of 1-20 µmol. Two hours after the treatment with test agents, mice were administered 10 µmol NNK (in 0.1 ml saline) by i.p. injection. Mice in the control groups were treated with either corn oil alone or test agents in corn oil, followed by i.p. injection of saline. The body weight in each group was measured at the beginning of the assay and then once every month until termination. At 16 weeks after the NNK or saline administration, mice were killed and pulmonary adenomas were counted.
Materials and methods

Chemicals
Statistical analysis
For each analysis, groups 2 through 9 were compared with group 1, and groups 10 through 12 were compared with group 9. For the body weight gain (expressed as crude difference from baseline and percent change from baseline) and tumor multiplicity, groups were compared using analysis of variance (ANOVA) followed by Dunnett's procedure (38) for comparing several treatment groups to a control. The χ 2 test was used to compare tumor incidence. 
Results
Inhibition of NNK metabolism in mouse lung microsomes by ITCs and their conjugates
The effects of PEITC and PHITC conjugates, together with parent ITCs, on NNK metabolism were studied in mouse lung microsomes. The rates of formation for the three major oxidative metabolites of NNK, keto-aldehyde, keto-alcohol, and NNK-N-oxide, were analyzed using a previously described HPLC method (35) . The dose-dependent inhibitions of these metabolic pathways of NNK by PEITC and its three conjugates are illustrated in Figure 1 . The inhibitory potency of the tested compounds, as indicated by their IC 50 values for these metabolic pathways of NNK, is summarized in Table I . As shown in previous studies, both PEITC and PHITC strongly inhibited the formation of all three NNK metabolites and PHITC was considerably more inhibitory than PEITC (13) . PEITCϪGSH, PEITCϪCys and PEITCϪNAC were also inhibitory, but were less potent than PEITC. The order of inhibitory potency of PEITC and its conjugates is PEITC Ͼ PEITCϪGSH Ͼ PEITCϪCys Ͼ PEITCϪNAC. PEITCϪNAC inhibited NNK metabolism by only 16-19% at 5 µM, the highest concentration studied. An increased inhibitory potency with increasing alkyl chain length was observed among the GSH conjugates of BITC, PEITC and PHITC. Unlike PEITC conjugates, PHITCϪGSH and PHITCϪNAC showed similar inhibitory activity as compared with PHITC toward all three NNK metabolic pathways.
Inhibition of NNK-induced lung tumorigenesis by ITCs and their thiol conjugates
When expressed as crude difference from baseline and percent change from baseline, no significant differences in body weight gain were found among groups (groups 2-8 versus group 1 and groups 10-12 versus group 9), indicating that the conjugates were not toxic at the doses tested. The tumor multiplicity and incidence are summarized in Table  II . The NNK-treated mice, which were pre-treated with vehicle alone, developed on average, 16.5 tumors/mouse and a 100% incidence. Mice in the control group without NNK treatment developed only 0.2 tumor/mouse with a 20% incidence. These background tumor responses are similar to those reported previously (37, 39) . Previous studies showed that PEITC given at 5 µmol/mouse inhibited 50% of tumor multiplicity, whereas PHITC at 1 µmol/mouse prevented the lung tumor formation caused by NNK (37) . As a positive control in the present study, at a single dose of 5 µmol, PEITC inhibited the tumor multiplicity by 28%. Although the percentage of inhibition is less than that reported previously at the same dose, this is a significant reduction compared with the NNK treated control group (group 1, P Ͻ 0.01). PEITCϪGSH at 4 µmol did not inhibit lung tumorigenesis. However, at 8 µmol, it reduced the tumor multiplicity by 32% (P Ͻ 0.01). Although it had no effects on the tumor incidence, PEITCϪNAC at both dose levels, 5 and 20 µmol/mouse, inhibited~30% of tumor multiplicity. We did not observe a dose-dependent inhibition by PEITCϪNAC. In contrast, PHITCϪNAC showed a much stronger inhibitory effect and a clear dose-related inhibition on tumor multiplicity and incidence. It reduced the tumor multiplicity from 16.5 to 5.0 at 1 µmol and completely 2145 blocked the NNK-induced lung tumorigenesis at 5 µmol, and only the background tumors were observed at this dose.
Discussion
In this study we demonstrated that the conjugates of ITC are inhibitory toward metabolism of NNK by mouse lung microsomes and NNK-induced lung tumorigenesis in A/J mice. Previous studies showed that the mechanism by which ITCs inhibit the NNK-induced lung tumorigenesis involves competitive or non-competitive inhibition of CYP isozymes such as 2A1 and 2B1 in mouse lung (7, 8, 13) . Recently, we reported that CYP 2E1, 1A1&2 and 2B1 are inhibited by ITC conjugates in rat liver and human liver microsomes (26, 27) . It is conceivable that inhibition of NNK metabolism by the conjugates is due to the inhibition of specific CYP isozymes, e.g., 2B1 in mouse lung microsomes. In the series of the GSH conjugates of BITC, PEITC and PHITC, the inhibitory potency increases with alkyl chain length in ITCs, a trend parallel to that observed with the parent ITC (13) . This correlation suggests that a common mechanism is shared by both ITCs and their conjugates. Based on the labile nature of the dithiocarbamate linkage in the conjugates and their ability to dissociate to free ITCs in aqueous solution, it is tempting to suggest that ITCs are the ultimate active species responsible for the inhibition (26, 40) . The IC 50 values for the conjugates of PEITC also appeared to support this theory. PEITCϪNAC is a much less potent inhibitor than PEITCϪGSH and PEITCϪCys in NNK metabolism. Our previous study showed that PEITCϪNAC has the longest half-life in the ligand exchange reaction with free thiol groups in buffer solution and, therefore, the slowest dissociation rate among the three conjugates (26) . This could explain the low inhibitory activity of PEITCϪNAC under the in vitro assay conditions. However, we did not observe the same trend in PHITC conjugates. PHITCϪGSH and PHITCϪNAC appeared to be as potent as PHITC itself with similar IC 50 values toward NNK metabolism. The different trends observed in the conjugates of PEITC and PHITC in the assay were also found in our previous study of P450 2B1 inhibition using the phenobarbital-induced rat liver microsomes (27) . In that case, the ratio of IC 50 values of PEITCϪGSH and PEITC (IC 50(PEITC-GSH) /IC 50 (PEITC) ϭ 7.5) was also greater than that of PHITCϪGSH and PHITC (IC 50(PHITCϪGSH) /IC 50(PHITC) ϭ 3.4) (27) . A possible explanation is that a shorter incubation time (3 min) was used in that study, making the assay more sensitive to the rate of dissociation. The current experiment involves a 20-min incubation time allowing a greater degree of dissociation, which renders the assay less sensitive to differences in the rates of dissociation. Also, we cannot rule out the possibility that the intact conjugate may also be an inhibitor. The direct inhibition of enzymatic activity by the conjugates might possibly explain the observed near equal potency between PHITC and its conjugates, but would not account for the trend with the PEITC conjugates. Apparently, further studies are needed to delineate the detailed mechanism of inhibition of CYPs by the conjugates. Results of the in vitro studies prompted us to examine the effects of conjugates on lung tumorigenesis in the tumor bioassay. PEITCϪGSH was included because of its high inhibitory activity in vitro. The NAC conjugates were used since they appear to be the most stable and are the major human urinary metabolites of the naturally occurring ITCs in cruciferous vegetables. All conjugates showed inhibitory activity at the doses studied, except for PEITCϪGSH at 4 µmol/mouse. Since PEITCϪGSH was much more inhibitory than PEITCϪNAC in vitro, we suspected that the lower activity of PEITCϪGSH observed in vivo could be attributed to its poorer absorption because of the water used as its vehicle compared with corn oil that was used for the other compounds. In group 2, PEITC at 5 µmol reduced tumor multiplicity by 28%. PEITCϪNAC had a similar effect at the same dose of 5 µmol, but did not increase inhibition at a much higher dose, 20 µmol. The reason for the lack of doseϪresponse is unclear and has to be examined in future studies. However, it is interesting to note that PEITCϪNAC was far less potent than PEITC and its two other conjugates in the inhibition of NNK metabolism in lung microsomes. The limited dissociation as discussed above may be responsible for the results obtained from the in vitro assay. Since PEITCϪNAC is more lipophilic than PEITCϪGSH on the basis of their retention time on a reverse-phase HPLC column (26) , the higher lipophilicity of PEITCϪNAC may facilitate its absorption, making it a more effective inhibitor. Our previous study showed that PHITC at 1 µmol/mouse inhibits tumor multiplicity and incidence by 100% (37) . In the present study, a complete inhibition was achieved by PHITCϪNAC at 5 µmol, but not at 1 µmol, suggesting somewhat lower activity of PHITCϪNAC than PHITC. On the other hand, PEITCϪNAC showed similar potency as its parent compound. Therefore, the differences in potency of ITC and its conjugate have to be evaluated based on the individual ITC. In general, the structureϪactivity relationships of the conjugates of PEITC and PHITC are parallel to those observed with parent ITCs, i.e., increase in alkyl chain length leads to increased tumor inhibitory potency (37, 39) . The increasing potency has been correlated with increased lipophilicity, which facilitates absorption and binding to CYP enzymes. However, many other factors need to be investigated such as transportation, metabolism and rate of dissociation, which may also influence the efficacy of the conjugates.
The demonstration of anticarcinogenic activity of ITC conjugates is an important step in developing more effective new chemopreventive agents. The thiol conjugates are products of the detoxification of ITCs in humans and are likely less toxic than their parent compounds. A recent study showed that a methylthiol conjugate of sulforaphane possessed similar activ-ity as the parent compound for the induction of phase II enzyme, whereas, its cytotoxicity in mouse hepatoma cells was reduced three-fold (41) . It has been reported that GSH and L-Cys conjugates of BITC are less toxic than BITC in RL-4 rat hepatocytes (30) . In A/J mice, L-Cys conjugates of BITC and 3-phenylpropyl ITC are less toxic than the ITCs at a high dose (100 µmol/mouse) (42). These results support the view that while the conjugates could be less toxic than ITCs, they still maintain the desired activity. The slow release of ITCs in tissues via dissociation of conjugates could be the reason for their activity. Although the potential role of GSH and other endogenous thiol compounds as carriers of ITC has been recognized (28,42,43), the exact mechanism for ITCinduced toxicity remains unknown. In addition to their pivotal role in the metabolism of ITC, thiols are themselves antioxidants and scavengers of reactive electrophiles and are involved in the detoxification of other xenobiotics (44) . Therefore, conjugates of NAC, Cys and GSH with ITCs can be viewed as hybrids of potential chemopreventive agents with distinct modes of action. The conjugates have a number of physical and chemical properties desirable for their potential use as chemopreventive agents as compared with the parent compounds. They are less pungent, more soluble and chemically stable and, more importantly, these conjugates are likely to be less toxic. Recent studies have shown that PHITC, a highly effective chemopreventive agent for lung tumorigenesis induced by NNK, enhances esophageal and colon carcinogenesis upon chronic administration (31, 32) . These results emphasize the need to design agents with minimal toxicity. The conjugates described here are promising alternatives for ITCs and could represent a new approach for improving their chemopreventive efficacy.
